Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.AngioDynamics buys FlowMedica’s benephit renal therapy product line
The transaction was structured as an asset purchase under which AngioDynamics will pay $1.75 million in cash for the assets of the business plus a contingent payment based
The transaction was structured as an asset purchase under which AngioDynamics will pay $1.75 million in cash for the assets of the business plus a contingent payment based
Cleared for the identification of toxigenic Clostridium difficile directly from stool specimens, the BD GeneOhm Cdiff assay targets the toxin B gene, found in virtually all toxigenic Clostridium
Utilizing more than 1,200 patient samples from the Quasar trial, the validation study will use prospectively defined endpoints to assess the clinical utility of the Oncotype DX colon
Elekta Compact is a competitive linear accelerator for high-quality conventional radiotherapy, configured for countries in need of rapid build-up of additional treatment capacity, said Elekta. Elekta Compact is
Under the terms of the agreement, Dor will sell 20 million common shares together with a five-year warrant to purchase up to 200 million shares of Dor common
Under the terms of the settlement agreements, Warner Chilcott has granted Watson a non-exclusive license to the US patents covering Loestrin 24 Fe and Femcon Fe (norethindrone, ethinyl
Tiopronin tablets are prescribed in several countries for the treatment of acute and chronic hepatitis B, and for the relief of drug-induced liver injury. However, this drug can
Mr Newell has been a senior executive within the biotechnology industry for more than 10 years. He served as the president of Aerovance, a clinical stage biotechnology company
Dr Morris joins Cyberonics from InnerPulse, a privately held cardiology-focused medical technology company in North Carolina, where he has served as director of program management and operations since
Atrium Biosurgery is engaged in the development of advancements in biological, mechanical and therapeutic solutions for soft tissue healing following trauma, surgery and or other interventional procedures that